-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Evolutionary Genomics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q4 2022.
- Evolutionary Genomics, Inc. Return On Equity for the quarter ending December 31, 2022 was 38.9 %, a 53.9% decline year-over-year.
- Evolutionary Genomics, Inc. annual Return On Equity for 2022 was 38.9 %, a 53.9% decline from 2021.
- Evolutionary Genomics, Inc. annual Return On Equity for 2021 was 84.3 %, a 59.7% decline from 2020.
- Evolutionary Genomics, Inc. annual Return On Equity for 2020 was 209 %, a 84.9% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)